Next, AMPK activity was inhibited through adenoviral delivery of small hairpin RNAs (shRNAs) targeting AMPKα2 to determine the role of hepatic AMPK activation in the prevention of hepatic steatosis in MKRN1-null mice (Fig. 4j and Supplementary Fig. 8). The gene discussed is MKRN1; the disease is fatty liver disease.